Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Voya Financial
VOYA
|
+$81.9M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$68.8M |
| 3 |
Goldman Sachs
GS
|
+$64.1M |
| 4 |
AbbVie
ABBV
|
+$58.2M |
| 5 |
Citigroup
C
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$85.8M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$60.3M |
| 3 |
Morgan Stanley
MS
|
+$52.6M |
| 4 |
Expedia Group
EXPE
|
+$47.8M |
| 5 |
Centene
CNC
|
+$41.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Financials | 14.02% |
| 3 | Technology | 13.59% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AREX
2551
DELISTED
Approach Resources Inc.
AREX
| $717K | ﹤0.01% |
104,623
-35,304
| -25% | -$266K |
|
2552
Cerus
CERS
$530M
| $712K | ﹤0.01% |
137,100
| – | – |
|
|
RALY
2553
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $710K | ﹤0.01% |
36,500
| – | – |
|
2554
Evolution Petroleum
EPM
$134M
| $709K | ﹤0.01% |
107,495
+3,551
| +3% | +$24.3K |
|
2555
Kratos Defense & Security Solutions
KTOS
$11.8B
| $708K | ﹤0.01% |
112,302
+3,116
| +3% | +$18.5K |
|
|
NWBO
2556
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $703K | ﹤0.01% |
70,700
+18,600
| +36% | +$163K |
|
|
PPBI
2557
DELISTED
Pacific Premier Bancorp
PPBI
| $701K | ﹤0.01% |
41,300
+16,900
| +69% | +$272K |
|
2558
Limoneira
LMNR
$254M
| $699K | ﹤0.01% |
31,407
+820
| +3% | +$18.4K |
|
|
UNTD
2559
DELISTED
UNITED ONLINE INC COM NEW
UNTD
| $695K | ﹤0.01% |
+44,326
| New | +$733K |
|
2560
Franklin Covey
FC
$238M
| $694K | ﹤0.01% |
34,157
+1,230
| +4% | +$24K |
|
2561
Winmark
WINA
$1.36B
| $685K | ﹤0.01% |
6,952
+164
| +2% | +$15.2K |
|
2562
Sociedad Química y Minera de Chile
SQM
$20.4B
| $683K | ﹤0.01% |
43,781
+6,039
| +16% | +$116K |
|
2563
York Water
YORW
$524M
| $683K | ﹤0.01% |
32,700
+9,600
| +42% | +$221K |
|
|
YDKN
2564
DELISTED
Yadkin Financial Corporation
YDKN
| $683K | ﹤0.01% |
32,562
| – | – |
|
|
AT
2565
DELISTED
Atlantic Power Corporation
AT
| $669K | ﹤0.01% |
217,000
-383,600
| -64% | -$1.17M |
|
2566
AerCap
AER
$23.6B
| $667K | ﹤0.01% |
14,548
+4,170
| +40% | +$198K |
|
2567
Option Care Health
OPCH
$3.64B
| $667K | ﹤0.01% |
45,900
-28,410
| -38% | -$481K |
|
|
KE
2568
Kimball Electronics
KE
$608M
| $665K | ﹤0.01% |
45,525
| – | – |
|
2569
Natural Health Trends
NHTC
$15.2M
| $664K | ﹤0.01% |
+16,013
| New | +$474K |
|
|
CASC
2570
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $664K | ﹤0.01% |
29,568
+7,985
| +37% | +$126K |
|
2571
Madrigal Pharmaceuticals
MDGL
$12.3B
| $661K | ﹤0.01% |
8,468
-1,008
| -11% | -$84.6K |
|
|
ZVO
2572
DELISTED
Zovio Inc. Common Stock
ZVO
| $660K | ﹤0.01% |
69,031
+1,476
| +2% | +$14K |
|
2573
Horizon Bancorp
HBNC
$1.05B
| $659K | ﹤0.01% |
59,364
+31,464
| +113% | +$335K |
|
2574
Barrett Business Services
BBSI
$766M
| $657K | ﹤0.01% |
72,328
+2,296
| +3% | +$23.2K |
|
2575
Stoneridge
SRI
$200M
| $653K | ﹤0.01% |
55,700
| – | – |
|
Similar funds
Charles Schwab's Q2 2015 Portfolio in Review
As of Q2 2015, Charles Schwab held 3,232 positions worth $72.4B, up 1.8% from $71.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2015 filing shows 150 new, 2,258 increased, 427 reduced and 137 closed positions. Its largest new stake was Citizens Financial Group: 394,487 shares worth $10.8M. The largest sale was Merck, an estimated $85.8M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- Charles Schwab's largest Q2 2015 buy was Citizens Financial Group: 394,487 shares worth $10.8M.
- Charles Schwab added most to Voya Financial in Q2 2015, an estimated $81.9M increase.
- Charles Schwab's biggest Q2 2015 reduction was Merck, cutting an estimated $85.8M.
- Charles Schwab fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $60.3M.
- Charles Schwab's ten largest holdings make up 14% of its $72.4B portfolio in Q2 2015.
- Charles Schwab opened 150 new positions and closed 137 in Q2 2015.
- Charles Schwab's portfolio value rose 1.8% quarter-over-quarter to $72.4B.
Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.